Skip to search formSkip to main contentSkip to account menu

Recombinant Oncolytic Poliovirus PVS-RIPO

Known as: PVS-RIPO, PVSRIPO 
A recombinant, live attenuated, nonpathogenic oncolytic virus containing the oral poliovirus Sabin type 1 in which the internal ribosomal entry site… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Malignant gliomas are undifferentiated or anaplastic gliomas. They remain incurable with a multitude of modalities, including… 
Review
2018
Review
2018
Mechanisms to elicit antiviral immunity, a natural host response to viral pathogen challenge, are of eminent relevance to cancer… 
2017
2017
CONTEXT - The oncolytic polio-rhinovirus recombinant (PVSRIPO) has demonstrated promise in currently ongoing phase I/II clinical… 
Review
2014
Review
2014
Recently, the century‐old idea of targeting cancer with viruses (oncolytic viruses) has come of age, and promise has been… 
2014
2010
2010
Many animal viruses exhibit proficient growth in transformed cells, a property that has been harnessed for the development of… 
Highly Cited
2006
Highly Cited
2006
PURPOSE: The toxicity and antitumor activity of regional intrathecal delivery of an oncolytic recombinant poliovirus, PVS-RIPO… 
Highly Cited
1995
Highly Cited
1995
In common bean, cytoplasmic male sterility has been associated with a unique sequence found in the mitochondrial genome…